“…Similarly, astaxanthin could suppress the activation of the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome in macrophages (Peng et al, 2020). Moreover, multiple in vivo studies have revealed the anti-inflammatory effects of astaxanthin in different disease models, including non-alcoholic fatty liver (Bhuvaneswari et al, 2014;Ni et al, 2015;Chiu et al, 2016;Jia et al, 2016), hepatic injury or fibrosis Han et al, 2018;Liu et al, 2018;Zhang Z. et al, 2020), kidney injury (Guo et al, 2021), myocardial injury (Xie et al, 2020), diabetes mellitus (Feng et al, 2020;Liu et al, 2020;Zhuge et al, 2021), arthritis (Park MH. et al, 2020;Kumar et al, 2020), gastroenteritis inflammation (Han et al, 2020;Chen Y. et al, 2021), acute pancreatitis (Yasui et al, 2011), asthma (Hwang et al, 2017), atopic dermatitis (Park et al, 2018;Park et al, 2019), and hyperosmoticity-induced dry eye (Li H. et al, 2020).…”